About Colabs Pharma
Colabs Pharma is a company based in Hyderabad (India) founded in 2014. It operates as a B2B and D2C. Colabs Pharma offers products and services including Scyllo-Inositol, Myo-Inositol, Moringa Supplements, Sodium Bicarbonate Injection, and Bug Repellents. Colabs Pharma operates in a competitive market with competitors including Laurus Labs, Symbiotec, Provepharm Life Solutions, Beijing Biostar Technologies and SeQuent, among others.
- Headquarter Hyderabad, India
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
- Legal Name Colabs Pharma Private Limited
- Date of Incorporation 08 Sep, 2014
- Jurisdiction Visakhapatnam, Andhra Pradesh, India
-
Annual Revenue
$60.75 K (USD)1251.2as on Mar 31, 2020
-
Net Profit
$916.15 (USD)171.12as on Mar 31, 2020
-
EBITDA
$1.5 K (USD)224.73as on Mar 31, 2020
-
Latest Funding Round
Not available
-
Investors
Not available
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Colabs Pharma
Colabs Pharma offers a comprehensive portfolio of products and services, including Scyllo-Inositol, Myo-Inositol, Moringa Supplements, Sodium Bicarbonate Injection, and Bug Repellents.
Supplement from microbial strains for Alzheimer's and Dementia treatment.
Health supplement combined with Glutathione for overall wellness.
Vitamin-rich cocktails to address metabolic disorders and cancer risks.
Sterile injection for acute renal disease and diabetes management.
Conjugated repellents offering protection against mosquitos without harm.
Funding Insights of Colabs Pharma
Detailed funding history for Colabs Pharma
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Colabs Pharma
Investment portfolio details for Colabs Pharma
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Colabs Pharma
Detailed financials for Colabs Pharma
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Colabs Pharma Comparisons
Peer comparison for Colabs Pharma
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Colabs Pharma
Colabs Pharma operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Laurus Labs, Symbiotec, Provepharm Life Solutions, Beijing Biostar Technologies and SeQuent, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Pharmaceutical and biotechnology company
|
|
| Locked | Locked | Locked |
Non-sterile steroid hormone-based APIs and intermediates are manufactured.
|
|
| Locked | Locked | Locked |
APIs and drug products are developed and valorized in pharmaceuticals.
|
|
| Locked | Locked | Locked |
APIs, intermediates, and biochemical reagents are developed and manufactured.
|
|
| Locked | Locked | Locked |
APIs are developed and manufactured for therapeutic areas.
|
|
| Locked | Locked | Locked |
Contract development, manufacturing, and analytical services for APIs are offered.
|
Detailed competitors of Colabs Pharma
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Colabs Pharma
Complete news archive for Colabs Pharma
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Colabs Pharma
Colabs Pharma was founded in 2014.
Colabs Pharma is headquartered in Hyderabad, India. It is registered at Hyderabad, Telangana, India.
Annual revenue of Colabs Pharma is $60.75K as on Mar 31, 2020.
Colabs Pharma specializes in developing and supplying advanced pharmaceutical solutions, including supplements like Scyllo-Inositol for Alzheimers and nutritional products such as Myo-Inositol. They focus on innovative formulations from microbial strains and collaborate with institutions like Indian Institute of Science Education. Based in India through partnerships in Hyderabad and Pune, they address metabolic disorders, cancer prevention, and acute treatments, serving healthcare professionals and consumers via B2B channels.
Colabs Pharma's top competitors include Laurus Labs, Symbiotec and Beijing Biostar Technologies.
Colabs Pharma offers Scyllo-Inositol, Myo-Inositol, Moringa Supplements, Sodium Bicarbonate Injection, and Bug Repellents.